1 row is stored for this page
| Field | Field type | Value |
|---|
| generic | String | Celecoxib |
| brand | String | Celebrex (oral capsules), Elyxyb (oral solution, for acute migraine) |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:NSAIDs|Non-steroidal anti-inflammatory (NSAID • selective COX-2)]] • [[:Category:Analgesics|Analgesic]] |
| mechanism | String | |
| uses | String | '"`UNIQ--vote-00000021-QINU`"', '"`UNIQ--vote-00000022-QINU`"', '"`UNIQ--vote-00000023-QINU`"', '"`UNIQ--vote-00000024-QINU`"', '"`UNIQ--vote-00000025-QINU`"', '"`UNIQ--vote-00000026-QINU`"', '"`UNIQ--vote-00000027-QINU`"', '"`UNIQ--vote-00000028-QINU`"' |
| starting_dose | String | Osteoarthritis: 200 mg PO once daily or 100 mg BID. Rheumatoid arthritis: 100-200 mg PO BID. Acute pain: 400 mg loading, then 200 mg every 12 hours |
| preparations | String | Capsules 50, 100, 200, 400 mg; Elyxyb oral solution 25 mg/mL |
| fda_max | String | 400 mg/day for chronic indications; higher for short-term acute pain |
| pill_id | Text | |
| routes | List of String, delimiter: , | Oral |
| onset | String | 30-60 minutes |
| duration | String | 12-24 hours |
| halflife | String | ~11 hours'"`UNIQ--ref-00000029-QINU`"' |
| bioavailability | String | ~99% (oral)'"`UNIQ--ref-0000002A-QINU`"' |
| pregnancy | String | Avoid from 20 weeks gestation onward per FDA's 2020 expanded NSAID warning (fetal renal dysfunction, oligohydramnios); contraindicated from 30 weeks (risk of premature ductus arteriosus closure)'"`UNIQ--ref-0000002B-QINU`"' |
| legal | String | [[USLegal:Prescription only|Rx-only]] in US |
